During the past decade, Aspirus Research Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aspirus Research Institute" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Amryt Pharma" with 1 trials sponsored, "AtriCure, Inc." with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aspirus Research Institute" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Aspirus Research Institute" are "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials), "Abdominal Aortic Aneurysm Without Rupture" (1 trials), "Acute Coronary Syndromes" (1 trials) and "Aortic Valve Stenosis" (1 trials). Many other conditions were trialed in "Aspirus Research Institute" in a lesser frequency.

Most popular intervention types in "Aspirus Research Institute" are "Drug" (7 trials), "Device" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Empagliflozin" (2 trials), "Acetylsalicylic acid" (1 trials), "Acetylsalicylic acid placebo" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aspirus Research Institute" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Aspirus Research Institute". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Aspirus Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aspirus Research Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".

Aspirus Research Institute has several departments that took part in Clinical trials: "Aspirus Cancer Care - Wisconsin Rapids" - 139 trials, "Langlade Hospital and Cancer Center" - 128 trials, "Aspirus Regional Cancer Center" - 191 trials, "Saint Michael's Hospital Cancer Center" - 31 trials, "Aspirus Heart and Vascular Institute - Research and Education" - 4 trials, "Wausau Heart and Lung Surgeons" - 2 trials